Global Artificial Blood Substitute Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Artificial Blood Substitute Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Artificial Blood Substitute Market Size Growth Rate by Type
  • 1.4.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
  • 1.4.3 Hemoglobin-based Oxygen Carrier (HBOC)
• 1.3 Market by Application
  • 1.3.1 Global Artificial Blood Substitute Market Size Growth Rate by Application
  • 1.3.2 Military
  • 1.3.3 Civil
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Artificial Blood Substitute Sales Estimates and Forecasts 2016-2027
• 2.2 Global Artificial Blood Substitute Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Artificial Blood Substitute Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Artificial Blood Substitute Regions by Sales
  • 2.4.1 Global Top Artificial Blood Substitute Regions by Sales (2016-2021)
  • 2.4.2 Global Top Artificial Blood Substitute Regions by Sales (2022-2027)
• 2.5 Global Top Artificial Blood Substitute Regions by Revenue
  • 2.5.1 Global Top Artificial Blood Substitute Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Artificial Blood Substitute Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Artificial Blood Substitute Sales by Manufacturers
  • 3.1.1 Global Top Artificial Blood Substitute Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Artificial Blood Substitute Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Artificial Blood Substitute Sales in 2020
• 3.2 Global Artificial Blood Substitute Revenue by Manufacturers
  • 3.2.1 Global Top Artificial Blood Substitute Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Artificial Blood Substitute Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Artificial Blood Substitute Revenue in 2020
• 3.3 Global Artificial Blood Substitute Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Artificial Blood Substitute Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Artificial Blood Substitute Sales by Type
  • 4.1.1 Global Artificial Blood Substitute Historical Sales by Type (2016-2021)
  • 4.1.2 Global Artificial Blood Substitute Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Artificial Blood Substitute Sales Market Share by Type (2016-2027)
• 4.2 Global Artificial Blood Substitute Revenue by Type
  • 4.2.1 Global Artificial Blood Substitute Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Artificial Blood Substitute Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Artificial Blood Substitute Revenue Market Share by Type (2016-2027)
• 4.3 Global Artificial Blood Substitute Price by Type
  • 4.3.1 Global Artificial Blood Substitute Price by Type (2016-2021)
  • 4.3.2 Global Artificial Blood Substitute Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Artificial Blood Substitute Sales by Application
  • 5.1.1 Global Artificial Blood Substitute Historical Sales by Application (2016-2021)
  • 5.1.2 Global Artificial Blood Substitute Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Artificial Blood Substitute Sales Market Share by Application (2016-2027)
• 5.2 Global Artificial Blood Substitute Revenue by Application
  • 5.2.1 Global Artificial Blood Substitute Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Artificial Blood Substitute Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Artificial Blood Substitute Revenue Market Share by Application (2016-2027)
• 5.3 Global Artificial Blood Substitute Price by Application
  • 5.3.1 Global Artificial Blood Substitute Price by Application (2016-2021)
  • 5.3.2 Global Artificial Blood Substitute Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Artificial Blood Substitute Market Size by Type
  • 6.1.1 North America Artificial Blood Substitute Sales by Type (2016-2027)
  • 6.1.2 North America Artificial Blood Substitute Revenue by Type (2016-2027)
• 6.2 North America Artificial Blood Substitute Market Size by Application
  • 6.2.1 North America Artificial Blood Substitute Sales by Application (2016-2027)
  • 6.2.2 North America Artificial Blood Substitute Revenue by Application (2016-2027)
• 6.3 North America Artificial Blood Substitute Market Size by Country
  • 6.3.1 North America Artificial Blood Substitute Sales by Country (2016-2027)
  • 6.3.2 North America Artificial Blood Substitute Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Artificial Blood Substitute Market Size by Type
  • 7.1.1 Europe Artificial Blood Substitute Sales by Type (2017-2027)
  • 7.1.2 Europe Artificial Blood Substitute Revenue by Type (2017-2027)
• 7.2 Europe Artificial Blood Substitute Market Size by Application
  • 7.2.1 Europe Artificial Blood Substitute Sales by Application (2017-2027)
  • 7.2.2 Europe Artificial Blood Substitute Revenue by Application (2017-2027)
• 7.3 Europe Artificial Blood Substitute Market Size by Country
  • 7.3.1 Europe Artificial Blood Substitute Sales by Country (2017-2027)
  • 7.3.2 Europe Artificial Blood Substitute Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Artificial Blood Substitute Market Size by Type
  • 8.1.1 Asia Pacific Artificial Blood Substitute Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Artificial Blood Substitute Revenue by Type (2018-2027)
• 8.2 Asia Pacific Artificial Blood Substitute Market Size by Application
  • 8.2.1 Asia Pacific Artificial Blood Substitute Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Artificial Blood Substitute Revenue by Application (2018-2027)
• 8.3 Asia Pacific Artificial Blood Substitute Market Size by Region
  • 8.3.1 Asia Pacific Artificial Blood Substitute Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Artificial Blood Substitute Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Artificial Blood Substitute Market Size by Type
  • 9.1.1 Latin America Artificial Blood Substitute Sales by Type (2019-2027)
  • 9.1.2 Latin America Artificial Blood Substitute Revenue by Type (2019-2027)
• 9.2 Latin America Artificial Blood Substitute Market Size by Application
  • 9.2.1 Latin America Artificial Blood Substitute Sales by Application (2019-2027)
  • 9.2.2 Latin America Artificial Blood Substitute Revenue by Application (2019-2027)
• 9.3 Latin America Artificial Blood Substitute Market Size by Country
  • 9.3.1 Latin America Artificial Blood Substitute Sales by Country (2019-2027)
  • 9.3.2 Latin America Artificial Blood Substitute Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Artificial Blood Substitute Market Size by Type
  • 6.1.1 Middle East and Africa Artificial Blood Substitute Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Artificial Blood Substitute Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Artificial Blood Substitute Market Size by Application
  • 6.2.1 Middle East and Africa Artificial Blood Substitute Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Artificial Blood Substitute Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Artificial Blood Substitute Market Size by Country
  • 6.3.1 Middle East and Africa Artificial Blood Substitute Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Artificial Blood Substitute Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 UAE

11 Company Profiles

• 11.1 Aurum Biosciences Ltd.
  • 11.1.1 Aurum Biosciences Ltd. Corporation Information
  • 11.1.2 Aurum Biosciences Ltd. Overview
  • 11.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Product Description
  • 11.1.5 Aurum Biosciences Ltd. Related Developments
• 11.2 HEMARINA SA
  • 11.2.1 HEMARINA SA Corporation Information
  • 11.2.2 HEMARINA SA Overview
  • 11.2.3 HEMARINA SA Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 HEMARINA SA Artificial Blood Substitute Product Description
  • 11.2.5 HEMARINA SA Related Developments
• 11.3 HbO2 Therapeutics
  • 11.3.1 HbO2 Therapeutics Corporation Information
  • 11.3.2 HbO2 Therapeutics Overview
  • 11.3.3 HbO2 Therapeutics Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 HbO2 Therapeutics Artificial Blood Substitute Product Description
  • 11.3.5 HbO2 Therapeutics Related Developments
• 11.4 KaloCyte Inc.
  • 11.4.1 KaloCyte Inc. Corporation Information
  • 11.4.2 KaloCyte Inc. Overview
  • 11.4.3 KaloCyte Inc. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 KaloCyte Inc. Artificial Blood Substitute Product Description
  • 11.4.5 KaloCyte Inc. Related Developments
• 11.5 SpheriTech Ltd.
  • 11.5.1 SpheriTech Ltd. Corporation Information
  • 11.5.2 SpheriTech Ltd. Overview
  • 11.5.3 SpheriTech Ltd. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 SpheriTech Ltd. Artificial Blood Substitute Product Description
  • 11.5.5 SpheriTech Ltd. Related Developments
• 11.6 NuvOx Pharma
  • 11.6.1 NuvOx Pharma Corporation Information
  • 11.6.2 NuvOx Pharma Overview
  • 11.6.3 NuvOx Pharma Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 NuvOx Pharma Artificial Blood Substitute Product Description
  • 11.6.5 NuvOx Pharma Related Developments
• 11.1 Aurum Biosciences Ltd.
  • 11.1.1 Aurum Biosciences Ltd. Corporation Information
  • 11.1.2 Aurum Biosciences Ltd. Overview
  • 11.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Product Description
  • 11.1.5 Aurum Biosciences Ltd. Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Artificial Blood Substitute Value Chain Analysis
• 12.2 Artificial Blood Substitute Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Artificial Blood Substitute Production Mode & Process
• 12.4 Artificial Blood Substitute Sales and Marketing
  • 12.4.1 Artificial Blood Substitute Sales Channels
  • 12.4.2 Artificial Blood Substitute Distributors
• 12.5 Artificial Blood Substitute Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Artificial Blood Substitute Industry Trends
• 13.2 Artificial Blood Substitute Market Drivers
• 13.3 Artificial Blood Substitute Market Challenges
• 13.4 Artificial Blood Substitute Market Restraints

14 Key Findings in The Global Artificial Blood Substitute Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details